Silence Therapeutics SLN
NASDAQ SLN
$19.67 +0.06 (+0.31%)
At close: Oct 21, 2026 · 4:00 PM EDT

Silence Therapeutics (SLN) Deferred Taxes (2024 - 2025)

Updated

Silence Therapeutics (SLN) recorded Deferred Taxes of $11,000 in the year ended Dec 31, 2025, down 98.7% from $845,000 a year earlier.

Analysis

Silence Therapeutics (SLN) Deferred Taxes (2024 - 2025) Analysis & Trends

Starting with the year ended Dec 31, 2022, Silence Therapeutics' Deferred Taxes history includes 4 years.

  • Annual Deferred Taxes has a three-year compound annual growth rate of -74.8% (years ended Dec 2022 to Dec 2025).
  • Per Business Quant data, SLN's Deferred Taxes was $845,000 in the year ended Dec 31, 2024 (-11.6%), $956,000 in the year ended Dec 31, 2023 (+39.0%) and $688,000 in the year ended Dec 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 1.05 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -479.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -195.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -544.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -291.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -587.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -1.32 Bn
10 Silence Therapeutics 927.96 Mn 855.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 1,000.00
Jun 30, 2025 10,000.00
Dec 31, 2024 324,000.00
Sep 30, 2024 49,000.00
Jun 30, 2024 228,000.00
Mar 31, 2024 244,000.00
API Access

Silence Therapeutics Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=SLN&period=max&api_key=YOUR_API_KEY